<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>multidisciplinary neuro-oncology &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/multidisciplinary-neuro-oncology/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:58:45 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>multidisciplinary neuro-oncology &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Advances in Treating Malignant Spinal Astrocytomas</title>
		<link>https://bioengineer.org/advances-in-treating-malignant-spinal-astrocytomas/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 04 Aug 2025 20:05:49 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[malignant spinal cord astrocytomas]]></category>
		<category><![CDATA[modern treatment strategies]]></category>
		<category><![CDATA[molecular targeted therapies]]></category>
		<category><![CDATA[multidisciplinary neuro-oncology]]></category>
		<category><![CDATA[radiotherapy advancements]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advances-in-treating-malignant-spinal-astrocytomas/</guid>

					<description><![CDATA[The landscape of malignant spinal cord astrocytomas presents one of the most formidable challenges in contemporary neuro-oncology, as these aggressive tumors remain notoriously difficult to treat and are associated with poor prognoses. Recent advances, however, are beginning to change the narrative. Emerging modalities in surgical techniques, radiotherapy, chemotherapy, and innovative targeted therapies collectively form the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">253023</post-id>	</item>
	</channel>
</rss>
